Rosenblum Mark J

CIK 0001329154

Exec VP Finance, CFO

Filings

Latest Nov 20, 2025

Issuers covered

Showing

8 of 8

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Rosenblum Mark J. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Rosenblum Mark J has filed

Ticker	Issuer	Filings	Last filed
SLRX	Salarius Pharmaceuticals, Inc.	8	Nov 20, 2025

8 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Nov 20, 2025	SLRXSalarius Pharmaceuticals, Inc.	PPurchase	20,000	$0.80	$16,000
Feb 22, 2024	SLRXSalarius Pharmaceuticals, Inc.	Holdings only	-	-	-
Feb 15, 2023	SLRXSalarius Pharmaceuticals, Inc.	AGrant	6,432	$0.00	$0
Jan 5, 2023	SLRXSalarius Pharmaceuticals, Inc.	AGrant	8,000	$0.00	$0
May 31, 2022	SLRXSalarius Pharmaceuticals, Inc.	PPurchase	28,000	$0.18	$5,040
May 5, 2022	SLRXSalarius Pharmaceuticals, Inc.	AGrant	10,000	$0.1863	$1,863
Mar 9, 2022	SLRXSalarius Pharmaceuticals, Inc.	PPurchase	76,246	$0.391	$29,812
Jan 21, 2022	SLRXSalarius Pharmaceuticals, Inc.	Holdings only	-	-	-

Showing 1-8 of 8

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.